LLY · Eli Lilly
Latest news, signals, and AI analysis for Eli Lilly (LLY) on Catalayer. Updated continuously as stories are indexed across our news feed.
Recent LLY News
Novo Nordisk CEO defends lawsuit against Eli Lilly: 'Competition has to be fair'
Eli Lilly and Company (LLY) vs. Novo Nordisk A/S (NVO): Is Lilly Pulling Ahead in the $100 Billion Obesity Market?
IBD 50 Stocks To Watch: Obesity Drug Giant Eli Lilly Offers New Buy Point
Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide
I Underestimated Eli Lilly: Retatrutide Changes The Risk/Reward (Rating Upgrade)
Eli Lilly vs. Novo Nordisk: Has GLP-1 Manufacturing Become the New Competitive Moat?
Related Tickers
$JNJ · Johnson & Johnson$PFE · Pfizer$MRK · Merck$ABBV · AbbVie$NVO · Novo Nordisk$GILD · Gilead SciencesFrequently Asked Questions
What sector does LLY belong to?
LLY (Eli Lilly) is classified under the Pharma sector on Catalayer. You can browse all news in this sector at /sector/pharma.
Where can I track real-time LLY news?
Catalayer aggregates LLY coverage from Reuters, Bloomberg, CNBC, MarketWatch, Yahoo Finance, Seeking Alpha, Barron’s, WSJ, Motley Fool, Benzinga, TipRanks and 20+ other sources. View the live feed at https://catalayer.com/stocks/LLY.
How fast are LLY news alerts on Catalayer?
News is polled every 30–60 seconds. LLY-related stories appear in your workspace within minutes of publication, and you can create a custom monitor to get instant alerts.
Does Catalayer provide AI analysis for LLY?
Yes. The Market Intelligence tier adds AI-powered event classification (monetary policy, earnings, guidance, M&A), directional impact (bullish/bearish), magnitude, and affected-sector analysis to every LLY story.
Is LLY covered in any Catalayer signal channels?
Signal channels and custom keyword monitors both support LLY. Free accounts get 1 monitor; Plus ($29/mo) unlocks 5 monitors with boolean rules across tickers, sectors, and topics.